161 related articles for article (PubMed ID: 3098235)
1. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.
Yu SH; Possmayer F
Biochem J; 1986 May; 236(1):85-9. PubMed ID: 3098235
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the small hydrophobic proteins associated with pulmonary surfactant.
Yu SH; Chung W; Olafson RW; Harding PG; Possmayer F
Biochim Biophys Acta; 1987 Oct; 921(3):437-48. PubMed ID: 3663690
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.
Yu SH; Possmayer F
Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500
[TBL] [Abstract][Full Text] [Related]
4. Proteolipid in bovine lung surfactant: its role in surfactant function.
Takahashi A; Fujiwara T
Biochem Biophys Res Commun; 1986 Mar; 135(2):527-32. PubMed ID: 3754441
[TBL] [Abstract][Full Text] [Related]
5. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
Notter RH; Shapiro DL; Ohning B; Whitsett JA
Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.
Revak SD; Merritt TA; Hallman M; Cochrane CG
Am Rev Respir Dis; 1986 Dec; 134(6):1258-65. PubMed ID: 3789526
[TBL] [Abstract][Full Text] [Related]
7. Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.
Sarin VK; Gupta S; Leung TK; Taylor VE; Ohning BL; Whitsett JA; Fox JL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2633-7. PubMed ID: 2320580
[TBL] [Abstract][Full Text] [Related]
8. Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses.
Yu SH; Wallace D; Bhavnani B; Enhorning G; Harding PG; Possmayer F
Pediatr Res; 1988 Jan; 23(1):23-30. PubMed ID: 3340440
[TBL] [Abstract][Full Text] [Related]
9. Sialic acid of lung surfactant apoprotein, SP 28-36, is not required for the Ca2+-mediated interactions between surfactant lipids and SP 28-36.
Efrati H; Hawgood S
Biochim Biophys Acta; 1987 Feb; 917(3):425-7. PubMed ID: 3801512
[TBL] [Abstract][Full Text] [Related]
10. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary corpora amylacea contain surfactant apoprotein.
Akino T; Mizumoto M; Shimizu H; Kuroki Y; Dempo K; Tsuda T; Yanai S; Mizuki M
Pathol Res Pract; 1990 Oct; 186(5):687-91; discussion 691-5. PubMed ID: 2287594
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake and processing of surfactant lipids and apoprotein SP-A by rat lung.
Young SL; Wright JR; Clements JA
J Appl Physiol (1985); 1989 Mar; 66(3):1336-42. PubMed ID: 2708254
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of fetal lung maturity by immunological measurement of fetal pulmonary surfactant apoproteins in amniotic fluid (author's transl)].
Hirano H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):889-98. PubMed ID: 6809865
[TBL] [Abstract][Full Text] [Related]
14. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pulmonary surfactant apoproteins by isoelectric focusing.
Katyal SL; Singh G
Biochim Biophys Acta; 1984 Jul; 794(3):411-8. PubMed ID: 6430347
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the apoproteins in pulmonary surfactant.
King RJ; Martin H; Mitts D; Holmstrom FM
J Appl Physiol Respir Environ Exerc Physiol; 1977 Apr; 42(4):483-91. PubMed ID: 577208
[TBL] [Abstract][Full Text] [Related]
17. Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G.
Lewis RW; Harwood JL; Tetley TD; Harris E; Richards RJ
Biochem Soc Trans; 1993 May; 21(2):206S. PubMed ID: 8359457
[No Abstract] [Full Text] [Related]
18. Intracellular metabolism of the apoproteins of pulmonary surfactant in rat lung.
King RJ; Martin H
J Appl Physiol Respir Environ Exerc Physiol; 1980 May; 48(5):812-20. PubMed ID: 6893834
[TBL] [Abstract][Full Text] [Related]
19. The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.
Suzuki Y; Curstedt T; Grossmann G; Kobayashi T; Nilsson R; Nohara K; Robertson B
Eur J Respir Dis; 1986 Nov; 69(5):336-45. PubMed ID: 3792469
[TBL] [Abstract][Full Text] [Related]
20. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
Wright JR; Wager RE; Hawgood S; Dobbs L; Clements JA
J Biol Chem; 1987 Feb; 262(6):2888-94. PubMed ID: 3818626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
